A look at whether JNJ's attempt to acquire Swiss medical device maker, Synthes is a good idea with Natasha Singer, The New York Times Reporter, and Damien Conover, Morningstar equity analyst.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT